BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36427698)

  • 1. KDM6B regulates M2 polarization of macrophages by modulating the stability of nuclear β-catenin.
    Du L; Dai B; Liu X; Zhou D; Yan H; Shen T; Wang D; Tan X
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166611. PubMed ID: 36427698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.
    Xun J; Du L; Gao R; Shen L; Wang D; Kang L; Chen C; Zhang Z; Zhang Y; Yue S; Feng S; Xiang R; Mi X; Tan X
    Theranostics; 2021; 11(14):6847-6859. PubMed ID: 34093857
    [No Abstract]   [Full Text] [Related]  

  • 3. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of epigenetic regulator KDM6B by
    Rana S; Maurya S; Mohapatra G; Singh S; Babar R; Chandrasekhar H; Chamoli G; Rathore D; Kshetrapal P; Srikanth CV
    Gut Microbes; 2021; 13(1):1986665. PubMed ID: 34696686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell Lymphoma.
    Shao R; Liu C; Xue R; Deng X; Liu L; Song C; Xie J; Tang H; Liu W
    Int J Biol Sci; 2024; 20(3):848-863. PubMed ID: 38250157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
    Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM6B Counteracts EZH2-Mediated Suppression of
    Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q
    Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis.
    Guo T; Han X; He J; Feng J; Jing J; Janečková E; Lei J; Ho TV; Xu J; Chai Y
    Elife; 2022 Feb; 11():. PubMed ID: 35212626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
    Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
    Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways.
    Johnstone AL; Andrade NS; Barbier E; Khomtchouk BB; Rienas CA; Lowe K; Van Booven DJ; Domi E; Esanov R; Vilca S; Tapocik JD; Rodriguez K; Maryanski D; Keogh MC; Meinhardt MW; Sommer WH; Heilig M; Zeier Z; Wahlestedt C
    Addict Biol; 2021 Jan; 26(1):e12816. PubMed ID: 31373129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone demethylase Kdm6b regulates the maturation and cytotoxicity of TCRαβ
    Zhang H; Hu Y; Liu D; Liu Z; Xie N; Liu S; Zhang J; Jiang Y; Li C; Wang Q; Chen X; Ye D; Sun D; Zhai Y; Yan X; Liu Y; Chen CD; Huang X; Eugene Chin Y; Shi Y; Wu B; Zhang X
    Cell Death Differ; 2022 Jul; 29(7):1349-1363. PubMed ID: 34999729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone demethylase KDM6B promotes epithelial-mesenchymal transition.
    Ramadoss S; Chen X; Wang CY
    J Biol Chem; 2012 Dec; 287(53):44508-17. PubMed ID: 23152497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase KDM6B regulates 1,25-dihydroxyvitamin D3-induced senescence in glioma cells.
    Sui A; Xu Y; Pan B; Guo T; Wu J; Shen Y; Yang J; Guo X
    J Cell Physiol; 2019 Aug; 234(10):17990-17998. PubMed ID: 30825201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β-catenin signaling.
    Xun J; Gao R; Wang B; Li Y; Ma Y; Guan J; Zhang Q
    FEBS Open Bio; 2021 Aug; 11(8):2273-2281. PubMed ID: 34165914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDM6B (JMJD3) and its dual role in cancer.
    Lagunas-Rangel FA
    Biochimie; 2021 May; 184():63-71. PubMed ID: 33581195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
    Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
    Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.